High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 3, 1996, Pages 463-466

  Eguchi, Katsumi ^a   Origuchi, Tomoki ^a   Takashima, Hiroyuki ^a   Iwata, Kokichi ^a   Katamine, Shigeru ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; JOINT RADIOGRAPHY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HIV SEROPREVALENCE; HTLV-I ANTIBODIES; HUMANS; JAPAN; JOINT DISEASES; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 0029916801     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390314     Document Type: Article

References (21)

1. Sato K, Maruyama I, Maruyama Y, Kitazima I, Nakazima Y, Higaki M, Yamamoto K, Miyasaka N, Osame M, Nishioka K: Arthritis in patients infected with human T lymphotropic virus type I: clinical and immunopathologic features. Arthritis Rheum 34:714-721, 1991
2. Nishioka K, Nakajima T, Hasunuma T, Sato K: Rheumatic manifestation of human leukemia virus infection. Rheum Dis Clin North Am 19:489-503, 1993
3. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Maruyama I, Nosaka T, Hatanaka M, Nishioka K: Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J Clin Invest 92:186-193, 1993
4. Iwakura Y, Tosu M, Yashida M, Takiguchi M, Sato K, Kitazima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026-1028, 1991
5. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y, Sawada T, Nagataki S: Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51:769-776, 1992
6. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, Miyamoto T: Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344:1116-1119, 1994
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
8. World Health Organization: Acquired immunodeficiency syndrome (AIDS): proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/ HTLV-II. Wkly Epidemiol Rec 65:281-283, 1990
9. Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T: Mother-to-child transmission of human T-cell leukemia virus type I. Jpn J Cancer Res 76:474-480, 1985
10. Tajima K, Tominaga S, Suchi T, Kawagoe T, Komoda T, Hinuma H, Oda T, Fujita K: Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gann 73:793-901, 1982
11. Schlesselman JJ: Case Control Studies: Design, Conduct and Analysis. New York, Oxford University Press, 1982
12. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949
13. Carson DA: Genetic factors in the etiology and pathogenesis of autoimmunity. FASEB J 6:2800-2805, 1992
14. DaSilva JAP: Sex hormones, glucocorticoids and autoimmunity: facts and hypothesis. Ann Rheum Dis 54:6-16, 1995
15. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52 (suppl):S39-S47, 1993
16. Ziegler B, Huang G-Q, Gay RE, Fassbender HG, Gay S: Immunohistological localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis. Am J Pathol 135:1-5, 1989
17. Aicher WK, Stransky G, Gay RE, Gay S: Synovial lining cells derived from patients with rheumatoid arthritis produce reverse transcriptase (abstract). Arthritis Rheum 34 (suppl 9):S177, 1991
18. Daenke S, Bangham CRM: Do T cells cause HTLV-I-associated disease? A taxing problem. Clin Exp Immunol 96:179-181, 1994
19. Nelson PN, Lever AML, Bruckner FE, Isenberg DA, Kessaris N, Hay FC: Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-I in rheumatological diseases although a minority of sera cross react with retroviral antigens. Ann Rheum Dis 53:749-754, 1994
20. Katamine S, Moriuchi R, Yamamoto T, Terada K, Eguchi K, Tsuji Y, Yamabe T, Miyamoto T, Hino S: HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet 343:1326-1327, 1994
21. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N: HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83:236-239, 1992